Ardeypharm GmbH
Quick facts
Phase 3 pipeline
- EcN-Suspension · Immunology / Gastroenterology
EcN-Suspension is a live biotherapeutic containing engineered Escherichia coli Nissle 1917 designed to modulate the gut microbiome and immune system.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: